Opinion: The world is relying on the United States to get value-based drug pricing right
STAT
MAY 6, 2024
has implications for the global pace and direction of innovation. Drug policy changes are being influenced by perceptions of the value of novel medicines relative to their budgetary impacts, with some believing that many medicines may not be worth their cost, creating an important role for health technology assessments (HTA).
Let's personalize your content